{"id":534808,"date":"2021-09-07T08:08:15","date_gmt":"2021-09-07T12:08:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/"},"modified":"2021-09-07T08:08:15","modified_gmt":"2021-09-07T12:08:15","slug":"spero-therapeutics-to-present-at-three-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/","title":{"rendered":"Spero Therapeutics to Present at Three Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CAMBRIDGE, Mass., Sept.  07, 2021  (GLOBE NEWSWIRE) &#8212; Spero Therapeutics, Inc.\u00a0(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23<sup>rd<\/sup> Annual Global Investment Conference, the Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit, and the 2021 Cantor Virtual Global Healthcare Conference, taking place virtually September 13 \u2013 15<sup>th<\/sup>, 2021, September 20 \u2013 23<sup>rd<\/sup>, 2021, and September 27 \u2013 30<sup>th<\/sup>, 2021, respectively.<\/p>\n<p align=\"justify\">Details on the presentations can be found below.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>H.C. Wainwright 23<\/strong><br \/>\n            <sup><br \/>\n              <strong>rd<\/strong><br \/>\n            <\/sup><br \/>\n            <strong> Annual Global Investment Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:16%;width:16%;min-width:16%;text-align: left;vertical-align: middle;vertical-align: top\">Presentation Date:<\/td>\n<td style=\"max-width:84%;width:84%;min-width:84%;text-align: left;vertical-align: middle;vertical-align: top\">Available on-demand starting at 7:00 AM ET on September 13, 2021<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Webcast Link:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <a href=\"https:\/\/journey.ct.events\/view\/56c64b06-9180-49d7-8e03-e8dd9ffbb8a8\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journey.ct.events\/view\/56c64b06-9180-49d7-8e03-e8dd9ffbb8a8<\/a><br \/>\n            \n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:16%;width:16%;min-width:16%;text-align: left;vertical-align: middle;vertical-align: top\">Presentation Date:<\/td>\n<td style=\"max-width:84%;width:84%;min-width:84%;text-align: left;vertical-align: middle;vertical-align: top\">September 22, 2021<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Time:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">9:55 AM ET<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Webcast Link:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <a href=\"https:\/\/wsw.com\/webcast\/oppenheimer16\/spro\/2825452\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/oppenheimer16\/spro\/2825452<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>2021 Cantor Virtual Global Healthcare Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:16%;width:16%;min-width:16%;text-align: left;vertical-align: middle;vertical-align: top\">Presentation Date:<\/td>\n<td style=\"max-width:84%;width:84%;min-width:84%;text-align: left;vertical-align: middle;vertical-align: top\">September 29, 2021<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Time:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">10:40 AM ET<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Webcast Link:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <a href=\"https:\/\/wsw.com\/webcast\/cantor12\/spro\/2118760\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/cantor12\/spro\/2118760<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">Webcasts of the presentations may also be accessed through Spero Therapeutics\u2019 website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0mSU0drFNa0NID8kfwG4NzdXyryL7B6t3NpcMIU1zd3F_82jS1FkQuZPbX5zwb_zWNfOYe9lfE67mWE9r_5tdOKRGPvwNvHBmEK7QNCwaAo=\" rel=\"nofollow noopener\" target=\"_blank\"><em>www.sperotherapeutics.com<\/em><\/a>) on the \u201cEvents and Presentations\u201d page under the \u201cInvestors and Media\u201d tab. Replays of the presentations will be available on the website following the conclusion of the respective events.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Spero<\/strong>\u00a0<strong>Therapeutics<\/strong><br \/>Spero Therapeutics, Inc.\u00a0is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug-resistant (MDR) bacterial infections and rare diseases.<\/p>\n<p align=\"justify\">Spero\u2019s lead product candidate, tebipenem HBr (tebipenem pivoxil hydrobromide; formerly SPR994), is being developed as the first oral carbapenem antibiotic for use in complicated urinary tract infections (cUTI) and acute pyelonephritis (AP). In\u00a0September 2020, Spero announced positive top-line results from its Phase 3 ADAPT-PO clinical trial of tebipenem HBr in cUTI and AP.<\/p>\n<p align=\"justify\">Spero is also developing SPR720 as a novel oral therapy product candidate for the treatment of rare, orphan pulmonary disease caused by non-tuberculous mycobacterial (NTM) infections.<\/p>\n<p align=\"justify\">Spero also has an IV-administered next generation polymyxin product candidate, SPR206, developed from its potentiator platform, which is being developed to treat MDR Gram-negative infections in the hospital setting.<\/p>\n<p align=\"justify\">For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VydGujCvzGVpGWCjkzzwTcRKbsd-bQ8Yf3mnAcj_QOY1nIYVL8G4GXjoMnTrDU_CorjxGvrhVz6AAemQ91FvuwxLTWgV4WbFx0SwVjGwlX-fnoOwC_3eoGb5BT9shQNj\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>https:\/\/sperotherapeutics.com<\/em><\/strong><\/a>.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong>\u00a0<br \/>Ted Jenkins<br \/>Vice President, Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IXTJobrpapswZtmH_KtAT5YtrtaW-EFymQlnFV_ulxtPizqZC5uukB_1TEIDULjRN_OhuzuBc81UOiG4crCM3ab6yGFOxokhF3E_isVUO0fWg5o98jtLA62hna2A2-_D\" rel=\"nofollow noopener\" target=\"_blank\">Tjenkins@sperotherapeutics.com<\/a><br \/>(617) 798-4039<\/p>\n<p>\n        <strong>Media Contact:<\/strong>\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b7IJMcj3cr0gLedhPo07LknCWWMFytjHp_bmkoouimOQBftnPwrbrJ69CG80yBIys7zfbQ-WDXnZ-THI7UFPDTW6YjkT-ihbxD1DLqX0CbU8gGIl-cZ3iM0cPdLpKn29\" rel=\"nofollow noopener\" target=\"_blank\">media@sperotherapeutics.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjFlMmEyZTMtY2U0Ni00YTliLWI0MjktNjJkOWE3NTdhYmE3LTExMDE5MzM=\/tiny\/Spero-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Spero Therapeutics, Inc.\u00a0(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, the Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit, and the 2021 Cantor Virtual Global Healthcare Conference, taking place virtually September 13 \u2013 15th, 2021, September 20 \u2013 23rd, 2021, and September 27 \u2013 30th, 2021, respectively. Details on the presentations can be found below. H.C. Wainwright 23 rd Annual Global &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Spero Therapeutics to Present at Three Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534808","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spero Therapeutics to Present at Three Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spero Therapeutics to Present at Three Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Spero Therapeutics, Inc.\u00a0(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, the Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit, and the 2021 Cantor Virtual Global Healthcare Conference, taking place virtually September 13 \u2013 15th, 2021, September 20 \u2013 23rd, 2021, and September 27 \u2013 30th, 2021, respectively. Details on the presentations can be found below. H.C. Wainwright 23 rd Annual Global &hellip; Continue reading &quot;Spero Therapeutics to Present at Three Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T12:08:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spero Therapeutics to Present at Three Upcoming Investor Conferences\",\"datePublished\":\"2021-09-07T12:08:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/\"},\"wordCount\":397,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/\",\"name\":\"Spero Therapeutics to Present at Three Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=\",\"datePublished\":\"2021-09-07T12:08:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spero Therapeutics to Present at Three Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spero Therapeutics to Present at Three Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Spero Therapeutics to Present at Three Upcoming Investor Conferences - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Spero Therapeutics, Inc.\u00a0(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, the Oppenheimer Fall Healthcare Life Sciences &amp; MedTech Summit, and the 2021 Cantor Virtual Global Healthcare Conference, taking place virtually September 13 \u2013 15th, 2021, September 20 \u2013 23rd, 2021, and September 27 \u2013 30th, 2021, respectively. Details on the presentations can be found below. H.C. Wainwright 23 rd Annual Global &hellip; Continue reading \"Spero Therapeutics to Present at Three Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T12:08:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spero Therapeutics to Present at Three Upcoming Investor Conferences","datePublished":"2021-09-07T12:08:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/"},"wordCount":397,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/","name":"Spero Therapeutics to Present at Three Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=","datePublished":"2021-09-07T12:08:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTYyNyM0Mzg3MjU2IzIwOTAzNjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spero-therapeutics-to-present-at-three-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spero Therapeutics to Present at Three Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534808"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534808\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}